Wildy logo
(020) 7242 5778
enquiries@wildy.com

Wildy’s Book News

Book News cover photo

Vol 21 No 11 Nov/Dec 2016

Book of the Month

Cover of Criminal Injuries Compensation Claims

Criminal Injuries Compensation Claims

Price: £99.95

Pupillage & Student Offers

Special Discounts for Pupils, Newly Called & Students

Read More ...


Secondhand & Out of Print

Browse Secondhand Online

Read More...


European Law and New Health Technologies (eBook)

Edited by: Mark L. Flear, Anne-Maree Farrell, Tamara K. Hervey, Therese Murphy

ISBN13: 9780191634857
Published: April 2013
Publisher: Oxford University Press
Country of Publication: UK
Format: eBook (ePub)
Price: £61.67 + £12.33 VAT
The amount of VAT charged may change depending on your location of use.


Once the order is confirmed an automated e-mail will be sent to you to allow you to download the eBook.

All eBooks are supplied firm sale and cannot be returned. If you believe there is a fault with your eBook then contact us on ebooks@wildy.com and we will help in resolving the issue. This does not affect your statutory rights.

This eBook is available in the following formats: ePub.


In stock.
Need help with ebook formats?


Also available as

Health is a matter of fundamental importance in European societies, both as a human right in itself, and as a factor in a productive workforce and therefore a healthy economy. New health technologies promise improved quality of life for patients suffering from a range of diseases, and the potential for the prevention of incidence of disease in the future. At the same time, new health technologies pose significant challenges for governments, particularly in relation to ensuring the technologies are safe, effective, and provide appropriate value for (public) money. To guard against the possible dangers arising from new health technologies, and to maximize the benefits, all European governments regulate their development, marketing, and public financing. In addition, several international institutions operating at European level, in particular the European Union, the Council of Europe, and the European Patent Office, have become involved in the regulation of new health technologies. They have done so both through traditional 'command and control' legal measures, and through other regulatory mechanisms, including guidelines, soft law, 'steering' through redistribution of resources, and private or quasi-private regulation. This collection analyses European law and its relationships with new health technologies. It uses interdisciplinary insights, particularly from law but also drawing on regulation theory, and science and technology studies, to shed new light on some of the key defining features of the relationships and especially the roles of risk, rights, ethics, and markets. The collection explores the way in which European law's engagement with new health technologies is to be legitimized, and discusses the implications for biological or biomedical citizenship.

Subjects:
Medical Law, eBooks
Contents:
1. Introduction

PART I: SETTING THE SCENE
2. Mapping Science and New Health Technologies: In Search of a Definition
3. Defining Features of the EU Law Approach to New Health Technologies
4. The Council of Europe and the Regulation of New Health Technologies
A Regulator's Response

PART II: LEGAL APPROACHES TO EUROPEAN LAW AND NEW HEALTH TECHNOLOGIES
5. Innovative Tissue Engineering and its Regulation: The Serach for Flexible Rules for Innovative Health Technologies
6. Looking After the Orphans? Treatments for Rare Diseases, EU Law, and the Ethics of Costly Healthcare
7. Exclusions in Patent Law as an Indirect Form of Regulation For New Health Technologies in Europe
8. New Health Technologies and their Impact on EU Product Liability Regulations
A Regulator's Response

PART III: REGULATORY THEORY, REGULATORY INNOVATION, EUROPEAN LAW AND NEW HEALTH TECHNOLOGIES
9. Risk, Legitimacy, and EU Regulation of Health Technologies
10. Something Old, Something New, Something Borrowed: Emerging Health Technologies and the Continuing Role of Existing Regulations
11. Science, Law, and the Medico-Industrial Complex in EU Pharmaceutical Regulation: The Deferiprone Controversy
12. The Governance of Therapeutic Nanoproducts in the European Union: A Model for New Health Technology Regulation?
A Regulator's Response

PART IV: NEW TECHNIQUES FOR RESEARCHING EUROPEAN LAW AND NEW HEALTH TECHNOLOGIES
13. Taking Technology Seriously: STS as Human Rights Method
14. Novel Rights Approaches to Health Technologies
15. Sociotechnical Innovation in Mental Health: Articulating Complexity
16. When Sperm Cannot Travel: Experiences of UK Patients Seeking Treatment Abroad
17. Where the Wild Things Are: Xenotechnologies and European Hybrid Regulation
A Regulator's Response

PART V: BRINGING IT ALL TOGETHER
Conclusion: European Law, New Health Technologies, New Challenges, New Approaches